DE4327732C1 - NO-containing gas mixture for the treatment of pulmonary disorders - Google Patents
NO-containing gas mixture for the treatment of pulmonary disordersInfo
- Publication number
- DE4327732C1 DE4327732C1 DE19934327732 DE4327732A DE4327732C1 DE 4327732 C1 DE4327732 C1 DE 4327732C1 DE 19934327732 DE19934327732 DE 19934327732 DE 4327732 A DE4327732 A DE 4327732A DE 4327732 C1 DE4327732 C1 DE 4327732C1
- Authority
- DE
- Germany
- Prior art keywords
- gas mixture
- containing gas
- treatment
- pulmonary disorders
- vpm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Revoked
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/02—Gases
- A61M2202/0266—Nitrogen (N)
- A61M2202/0275—Nitric oxide [NO]
Abstract
Description
Die Erfindung betrifft ein NO-haltiges Gasgemisch zur Behandlung pulmonaler Erkrankungen nach dem Oberbegriff des Anspruches 1.The invention relates to a gas mixture containing NO Treatment of pulmonary diseases according to the generic term of claim 1.
Die NO-Therapie bei Erwachsenen mit ARDS (adult res piratory distress syndrome) ist bekannt. Hierbei werden dem künstlich beatmeten Patienten über die Atemluft ge gebenenfalls verhältnismäßig hohe Konzentrationen von NO aus einem mehrere 100 vpm NO enthaltenden Gasbehäl ter zugeführt, maximal bis etwa 60 vpm. Das NO wirkt blutdrucksenkend auf den Bluthochdruck im Lungenkreis lauf, hat aber keine Wirkung auf den Blutdruck des ge samten Kreislaufes. Wegen der hohen Giftigkeit des NO und des zwangsläufig entstehenden NO2, sowie bedingt durch die künstliche Beatmung und der daraus resultie renden kleinen kontrollierten NO-Dosiermenge, ist bei der Verabreichung des NO ein großer Überwachungsaufwand erforderlich; vgl. dazu insbesondere R. C. Bone, The New England Journal of Medicine, Vol. 328, No. 6, Feb. 11, 1993, S. 431-432, sowie A. Benzing u. a., Anaesthesist 42 (1993), Springer-Verlag Berlin, S. 175-178.NO therapy in adults with ARDS (adult res piratory distress syndrome) is known. Here, the artificially ventilated patient via the breathing air ge possibly relatively high concentrations of NO from a gas container containing several 100 vpm NO, up to a maximum of about 60 vpm. The NO has a hypotensive effect on the high blood pressure in the pulmonary circulation, but has no effect on the blood pressure of the entire circulation. Because of the high toxicity of the NO and the inevitably arising NO 2 , as well as due to the artificial ventilation and the resulting small controlled NO dosage, a great deal of monitoring is required when administering the NO; see. in particular RC Bone, The New England Journal of Medicine, Vol. 328, No. 6, Feb. 11, 1993, pp. 431-432, and A. Benzing et al., Anaesthesist 42 (1993), Springer-Verlag Berlin, pp. 175-178.
Es ist erstrebenswert, die NO-Therapie auch bei solchen Patienten anzuwenden, die spontan atmen und gegebenen falls nicht stationär behandelt werden, damit auch diese Patientengruppe von den Vorteilen der NO-Therapie pro fitieren kann.It is worth striving for NO therapy even for those Apply to patients who breathe spontaneously and given if not treated in hospital, so this too Patient group of the benefits of NO therapy pro can fit.
Der Erfindung liegt daher die Aufgabe zugrunde, ein für diesen Zweck geeignetes NO-haltiges Gasgemisch zur Ver fügung zu stellen, welches keinen großen Überwachungs aufwand erforderlich macht.The invention is therefore based on the object for this purpose suitable NO-containing gas mixture for ver to provide, which is not a major surveillance effort required.
Ausgehend von dem im Oberbegriff des Anspruches 1 be rücksichtigten Stand der Technik ist diese Aufgabe er findungsgemäß gelöst mit den im kennzeichnenden Teil des Anspruches 1 angegebenen Merkmalen.Based on the be in the preamble of claim 1 considering the state of the art, this task is he solved according to the invention with those in the characterizing part of claim 1 specified features.
Eine vorteilhafte Weiterbildung der Erfindung ist im Unteranspruch angegeben.An advantageous development of the invention is in Subclaim specified.
Bei der praktischen Anwendung des erfindungsgemäßen Gasgemisches wird dieses mit 100%igem medizinischem Sauerstoff so vermischt, daß ein Atemgas aus etwa 30- 50% O2, Rest NO und N2, entsteht. Es ist daher nur sicherzustellen, daß der O2-Gehalt innerhalb der Gren zen von ca. 21-50% eingestellt bleibt. Durch die Messung der O2-Konzentration ist der NO-Anteil leicht einstellbar, ohne daß er meßtechnisch erfaßt werden muß. Bei patientennaher Einspeisung des Gemisches bleibt die Bildung des giftigen NO2 äußerst gering. Gut bewährt hat sich in der praktischen Anwendung ein Gemisch mit 10-16 vpm NO in Stickstoff. In the practical application of the gas mixture according to the invention, it is mixed with 100% medical oxygen in such a way that a breathing gas of approximately 30-50% O 2 , the rest NO and N 2 , is formed. It is therefore only necessary to ensure that the O 2 content remains within the limits of approx. 21-50%. By measuring the O 2 concentration, the NO portion can be easily adjusted without having to be measured. When the mixture is fed in close to the patient, the formation of the toxic NO 2 remains extremely low. A mixture with 10-16 vpm NO in nitrogen has proven itself in practical use.
Das erfindungsgemäße NO-haltige Gemisch und der medizi nische O2 können auch in zwei kleinen Speichern, z. B. Druckdosen, enthalten sein, die mit fixeingestellten Entnahmearmaturen versehen sind. Eine solche kleine, tragbare Therapieeinheit benötigt keine Steuerung und Kontrolle, so daß sie auch von einem Patienten bei sich zu Hause, beispielsweise bei einem Asthmaanfall, einge setzt werden kann.The NO-containing mixture according to the invention and the medicinal African O 2 can also in two small memories, for. B. pressure sockets are included, which are provided with fixed removal taps. Such a small, portable therapy unit does not require control and monitoring, so that it can also be used by a patient at home, for example in the event of an asthma attack.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19934327732 DE4327732C1 (en) | 1993-08-18 | 1993-08-18 | NO-containing gas mixture for the treatment of pulmonary disorders |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19934327732 DE4327732C1 (en) | 1993-08-18 | 1993-08-18 | NO-containing gas mixture for the treatment of pulmonary disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
DE4327732C1 true DE4327732C1 (en) | 1994-09-01 |
Family
ID=6495448
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19934327732 Revoked DE4327732C1 (en) | 1993-08-18 | 1993-08-18 | NO-containing gas mixture for the treatment of pulmonary disorders |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE4327732C1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19634530A1 (en) * | 1996-08-27 | 1998-03-05 | Messer Griesheim Gmbh | Alteration of formation rate or half-life of reactive molecular species |
US5904938A (en) * | 1995-02-16 | 1999-05-18 | The General Hospital Corporation | Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3621425A1 (en) * | 1986-06-25 | 1988-01-14 | Messer Griesheim Gmbh | DEVICE FOR GENERATING A COLD TREATMENT GAS FOR CRYOTHERAPY |
DE3938889A1 (en) * | 1989-11-24 | 1991-05-29 | Messer Griesheim Gmbh | TEMPERATURE TREATMENT CHAMBER FOR CARRYING OUT THERAPEUTIC PROCEDURES |
WO1992010228A1 (en) * | 1990-12-05 | 1992-06-25 | The General Hospital Corporation | Devices for treating pulmonary vasoconstriction and asthma |
DE4208521A1 (en) * | 1992-03-17 | 1993-09-30 | Heyer Gmbh Carl | Inhalation anaesthetics recovery - dries the gas mixture for active carbon adsorption and catalyst to release nitrogen and oxygen into atmosphere and remainder cooled to a fluid for storage or disposal |
-
1993
- 1993-08-18 DE DE19934327732 patent/DE4327732C1/en not_active Revoked
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3621425A1 (en) * | 1986-06-25 | 1988-01-14 | Messer Griesheim Gmbh | DEVICE FOR GENERATING A COLD TREATMENT GAS FOR CRYOTHERAPY |
DE3938889A1 (en) * | 1989-11-24 | 1991-05-29 | Messer Griesheim Gmbh | TEMPERATURE TREATMENT CHAMBER FOR CARRYING OUT THERAPEUTIC PROCEDURES |
WO1992010228A1 (en) * | 1990-12-05 | 1992-06-25 | The General Hospital Corporation | Devices for treating pulmonary vasoconstriction and asthma |
DE4208521A1 (en) * | 1992-03-17 | 1993-09-30 | Heyer Gmbh Carl | Inhalation anaesthetics recovery - dries the gas mixture for active carbon adsorption and catalyst to release nitrogen and oxygen into atmosphere and remainder cooled to a fluid for storage or disposal |
Non-Patent Citations (6)
Title |
---|
BENZING, A., u.a.: Anaesthesist 42(1993), S. 175-178 * |
BONE, R.C.: The New England Journal of Medicine, Vol. 328, 6, Feb. 11, 1993, S. 431-432 * |
DE-Z: SCHMIDT, H. - BÖHME, E.: Med.Mo.Pharm., 13, 3, 1990, S. 74-81 * |
FROSTELL,C.G. et.al.: Anaesthesiology 78, 3, Mai 1993, S. 427-435 * |
MANG, H. u.a.: Gefahren und Möglichkeiten der Therapie mit inhaliertem Stickstoffmonoxid, Intensivmed. 29(1992), S. 107-113 * |
SCHRÖDER, H.: aaO, 15, 5, 1992, S. 134-139 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5904938A (en) * | 1995-02-16 | 1999-05-18 | The General Hospital Corporation | Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
US6063407A (en) * | 1995-02-16 | 2000-05-16 | The General Hospital Corporation | Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
DE19634530A1 (en) * | 1996-08-27 | 1998-03-05 | Messer Griesheim Gmbh | Alteration of formation rate or half-life of reactive molecular species |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3533557C2 (en) | Measuring device for monitoring the CO¶2¶ content, the oxygen consumption and the respiratory quotient of a patient | |
DE69724202T2 (en) | Method and device for mixing gases | |
EP0857284B1 (en) | Process for providing one or a plurality of rooms with an increased oxygen supply | |
DE4115124A1 (en) | DEODORIZATION AND / OR STERILIZATION DEVICE | |
DE4327732C1 (en) | NO-containing gas mixture for the treatment of pulmonary disorders | |
DE10210292A1 (en) | Artificial respiratory system based on thermal radiation with Co¶2¶ absorbent and canister for use therein | |
DE4327731C1 (en) | NO-containing gas mixture for the treatment of pulmonary disorders | |
EP0467362A1 (en) | Ventilation kit | |
DE2837281A1 (en) | Respirable gas supply for aircraft cabins - by adsorptive removal of nitrogen from compressed air | |
DE2943365C2 (en) | ||
DE4134384A1 (en) | MODIFIED HUMINATES, METHOD FOR THEIR PRODUCTION AND USE | |
DE2916071A1 (en) | METHOD AND DEVICE FOR DERIVING A STUNNING AGENT | |
Stewart et al. | Arterial blood gases before, during, and after nitrous oxide: oxygen administration | |
DE10261809A1 (en) | Regulating oxygen content in closed room involves mixing oxygen-free gas and gas mixture containing oxygen, especially nitrogen/oxygen mixture, with ventilation system at raised internal pressure | |
Schmid et al. | Hochfrequenzbeatmung | |
DE690972C (en) | Device for improving room air | |
DE19832129C1 (en) | Medical gas mixture containing ozone and oxygen for prevention of reperfusion damage in treatment of e.g. ulcers, burns, infections and oedemas | |
DE19634530A1 (en) | Alteration of formation rate or half-life of reactive molecular species | |
Lercher | Glyoxalase 1 activity in atherosclerotic lesions: is there an association with serum haemoglobin A1c? | |
DE4243679A1 (en) | Multi gas mixer | |
Fillmore et al. | Curare sensitivity in myasthenia gravis | |
DE8104474U1 (en) | DEVICE FOR PRODUCING AN AEROSOL BY MEANS OF ULTRASOUND | |
Merkle et al. | Influence of Factor XIII on Wound Healing Under Normal and Pathophysiologic Conditions | |
CH226793A (en) | Device for performing anesthesia. | |
Kowald | High-Frequency Oscillatory Ventilation (HFOV) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8100 | Publication of the examined application without publication of unexamined application | ||
D1 | Grant (no unexamined application published) patent law 81 | ||
8363 | Opposition against the patent | ||
8331 | Complete revocation |